Business Context and Reporting Period
This Form 8-K Current Report, dated January 22, 2021, details a significant leadership transition at Inogen, Inc. (INGN). The Board of Directors appointed Nabil Shabshab as President and Chief Executive Officer (CEO) and a Class II Director, effective February 8, 2021. He succeeds Scott Wilkinson, who is retiring from his roles as President, CEO, and Director on the same effective date.
Key Financial Metrics and Compensation
This filing does not report operational financial metrics such as revenue, profit, cash flow, or debt. The financial data provided relates exclusively to the compensation arrangements for the new CEO and the transition package for the retiring CEO.
- New CEO Base Salary: $650,000 annually.
- New CEO Target Bonus: 85% of base salary.
- New CEO Sign-on Bonus: $1.7 million cash (subject to pro-rata repayment if terminated for cause or resignation without good reason within 2 years).
- New CEO Equity Awards:
- New Hire RSU Award: Initial value of approximately $1.8 million.
- 2021 Annual Award: Initial value of approximately $2.0 million (split between time-based RSUs and performance-based PSUs).
- Future Annual Awards: Eligible for awards with an initial value of not less than $2.0 million starting in 2022.
- Relocation Expenses: Up to $100,000 gross (subject to pro-rata repayment if terminated for cause or resignation without good reason within 2 years).
- Retiring CEO Transition: Scott Wilkinson will receive his current base salary and benefits until June 4, 2021, plus COBRA premium reimbursement for up to 18 months.
Material Changes
The primary material change is the departure of the long-serving CEO, Scott Wilkinson, and the appointment of Nabil Shabshab. Mr. Shabshab brings experience from Becton Dickinson and Company, where he served as Worldwide President of Diabetes Care and Digital Health. The filing notes no other material changes to the company's business operations or financial status in this specific report.
Outlook, Risks, and Contingencies
Management Commentary: The Board appointed Mr. Shabshab upon the recommendation of the Nominating and Governance Committee. A press release announcing these changes is planned for a future date.
Severance and Change of Control:
- Termination without Cause/Good Reason: Mr. Shabshab is eligible for 24 months of base salary, COBRA benefits, and accelerated vesting of New Hire RSUs if termination occurs within 2 years.
- Change of Control: If terminated without cause or resigns for good reason during the Change of Control Period, Mr. Shabshab receives 24 months of salary, COBRA benefits, and full vesting of all outstanding equity awards (including performance criteria deemed satisfied at target level).
- Clawback Provisions: The sign-on bonus and relocation expenses are subject to repayment if Mr. Shabshab is terminated for cause or resigns without good reason within the first two years.
Investor Verification Checklist
- Verify the effective date of the leadership transition (February 8, 2021) and the duration of the transition period for the outgoing CEO.
- Review the full text of the Employment and Severance Agreement (Exhibit 10.1) for specific definitions of "cause" and "good reason."
- Confirm the vesting schedules and performance criteria for the $3.8 million in initial equity awards granted to the new CEO.
- Monitor the upcoming press release for additional strategic context regarding the leadership change.
- Note that this filing contains no operational financial results; refer to the most recent 10-K or 10-Q for revenue and earnings data.